Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

October 30, 2024

Study Completion Date

June 30, 2025

Conditions
Acquired Thrombotic Thrombocytopenic Purpura
Interventions
DEVICE

ADAMTS13 Activity Assays

"In this study the measurement of ADAMTS13 activity will be assessed with three different commercial kits:~1. HemosIL AcuStar ADAMTS13 Activity Assay (Instrumentation Laboratory, Bedford, Massachusetts, United States)~2. ELISA, DG-EIA ADAMTS13 Activity (Diagnostic Grifols®, Spain)~3. FRETS-VWF73 for ADAMTS13 Activity Assay~Three kits will be used with all patients."

Trial Locations (6)

15006

RECRUITING

Complejo Hospitalario Universitario A Coruña, A Coruña

3004-561

RECRUITING

Centro Hospitalar e Universitario de Coimbra, Coimbra

Unknown

RECRUITING

Hospital Clinic de Barcelona, Barcelona

RECRUITING

Hospital Clínico San Carlos, Madrid

RECRUITING

Hospital Gregorio Marañon, Madrid

RECRUITING

Hospital La Fe de Valencia, Valencia

All Listed Sponsors
lead

Fundación Española de Hematología y Hemoterapía

OTHER